Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Mar;3(1):111-6.
doi: 10.1007/BF00917326.

Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole

Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole

D E Griswold et al. Inflammation. 1978 Mar.

Abstract

The effect of levamisole upon cell-mediated immunity was investigated using the oxazolone-induced contact sensitivity response in immunosuppressed and nonimmunosuppressed C57Bl male mice. Mice were sensitized to oxazolone on day 0, and where appropriate, methotrexate (1 mg/kg, p.o.) was administered on days 1 and 2. On day 3, levamisole (5--50 mg/kg, p.o., base) was administered. One hour later, the animals were challenged with oxazolone on the left hindpaw. Twenty-four hours after challenge, the resulting edema was read plethysmographically. Levamisole, in the absence of immunosuppression, had no significant effect upon the oxazolone response whereas, in the face of immunosuppression, restoration of oxazolone responsiveness was observed. These results were suggested to be due to (1) the ability of levamisole to stimulate opposing suppressor and effector components of the oxazolone response coupled with (2) an apparent alteration of suppressor influence by methotrexate allowing levamisole to enhance an unencumbered effector cell population.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br Med J. 1974 Dec 7;4(5944):592 - PubMed
    1. Acta Allergol. 1975 Apr;30(1):9-18 - PubMed
    1. Cell Immunol. 1974 Mar 30;11(1-3):198-204 - PubMed
    1. J Exp Med. 1975 Mar 1;141(3):697-702 - PubMed
    1. Cancer Treat Rep. 1976 Mar;60(3):217 - PubMed